Related Experiment Videos
Chronic lymphocytic leukemia: a monoclonal disease
American Journal of Hematology
|September 1, 1982
Summary
This study on chronic lymphocytic leukemia (CLL) found that the cancerous B lymphocytes had a single G6PD variant, while other cells showed multiple variants. This suggests CLL originates from a later developmental stage.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Chronic lymphocytic leukemia (CLL) is a malignancy of mature B lymphocytes.
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked genetic disorder.
- Clonal analysis is crucial for understanding leukemia origins.
Purpose of the Study:
- To investigate the cellular origin of chronic lymphocytic leukemia (CLL) in a patient.
- To determine the clonality of B lymphocytes, T cells, and erythrocytes in a CLL patient.
- To analyze the expression of glucose-6-phosphate dehydrogenase (G6PD) variants in different cell types.
Main Methods:
- Monoclonal antibody typing for surface immunoglobulin on B lymphocytes.
- Analysis of G6PD variants (G6PD A and G6PD B) in B lymphocytes, T cells, and erythrocytes.
- Assessment of cellular clonality based on G6PD expression patterns.
Main Results:
- The patient's CLL cells exhibited monoclonal B lymphocytes expressing a single G6PD variant (G6PD A).
- Erythrocytes and T cells displayed polyclonal populations with both G6PD A and G6PD B variants.
- This indicates that the CLL clone originated after T and B lymphocyte differentiation.
Conclusions:
- The findings suggest that the CLL clone arose from a progenitor cell at a later developmental stage than T and B lymphocyte differentiation.
- Erythrocytes in this patient did not originate from a stem cell affected by the CLL process.
- G6PD analysis provides a valuable tool for determining clonality in hematological malignancies.